| Literature DB >> 31336899 |
Zhangyuan Yan1, Shitong Wen1, Meng Ding2, Huixian Guo1, Cuiying Huang1, Xintong Zhu1, Junyi Huang1, Zhigang She2, Yuhua Long3.
Abstract
Six new polyketides, including one coumarin (1), two isocoumarins (2 and 3), dihydroradicinin (4), and two benzofuranone derivatives (7 and 8), together with seven known analogues (5-6 and 9-13) were isolated from the culture of the mangrove endophytic fungus Epicoccum nigrum SCNU-F0002. The structures were elucidated on the interpretation of spectroscopic data. The absolute configuration of Compounds 2 and 3 were determined by comparison of their ECD spectra with the data of their analogue dihydroisocoumarins described in the literature. The absolute configuration of 4 was determined by single-crystal X-ray diffraction. All the compounds were screened for their antioxidant, antibacterial, anti-phytopathogenic fungi and cytotoxic activities. Using a DPPH radical-scavenging assay, Compounds 10-13 showed potent antioxidant activity with IC50 values of 13.6, 12.1, 18.1, and 11.7 μg/mL, respectively. In addition, Compounds 6 and 7 showed antibacterial effects against Bacillus subtilis (ATCC 6538), Escherichia coli (ATCC 8739), and Staphylococcus aureus (ATCC 6538), with MIC values in the range of 25-50 μg/mL.Entities:
Keywords: antibacterial effect; antioxidant activity; benzofuranone derivative; coumarin; dihydroradicinin
Year: 2019 PMID: 31336899 PMCID: PMC6669579 DOI: 10.3390/md17070414
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Chemical structures of 1–13.
1H (600 MHz) and 13C (150 MHz) NMR Data for 1–3.
| Position | 1 a | 2 b | 3 b | |||
|---|---|---|---|---|---|---|
| δC | δH( | δC | δH( | δC | δH( | |
| 1 | 165.2, C | 164.9, C | ||||
| 2 | 156.3, C | |||||
| 3 | 142.0, C | 80.3, CH | 4.48, m | 79.5, CH | 4.50, m | |
| 4 | 113.7, CH | 7.40, s | 34.3, CH2 | 2.88, m | 34.4, CH2 | 2.88, m |
| 4a | 112.4, C | 133.2, C | 133.0, C | |||
| 5 | 129.4, CH | 8.10, s | 124.3, CH | 6.95, d (8.2) | 124.3, CH | 6.94, d (8.2) |
| 6 | 111.0, C | 123.0, CH | 7.10, d (8.2) | 123.0, CH | 7.10, d (8.2) | |
| 7 | 153.8, C | 151.5, C | 150.5, C | |||
| 8 | 103.3, CH | 6.90, s | 150.5, C | 151.5, C | ||
| 8a | 161.2, C | 119.4, C | 119.3, C | |||
| 9 | 171.1, C | 32.2, CH2 | 1.83, m | 31.0, CH2 | 2.05, m | |
| 10 | 56.1, OCH3 | 3.79, s | 29.1, CH2 | 1.69, m | 30.6, CH2 | 2.54, m |
| 11 | 62.5, CH2 | 3.63, t (6.0) | 177.1, C | |||
| 12 | 61.9, OCH3 | 3.87, s | 61.9, OCH3 | 3.86, s | ||
a Measured in DMSO-d6; b Measured in Methanol-d4.
Figure 2Key COSY (bold line) and HMBC (arrow) correlations of Compounds 1–4, 7, and 8.
Figure 3ECD spectra of Compounds 2 and 3.
1H (600 MHz) and 13C (150 MHz) NMR Data for 4 and 7–8.
| Position | 4 a | 7 b | 8 c | |||
|---|---|---|---|---|---|---|
| δC | δH( | δC | δH( | δC | δH( | |
| 1 | 173.4, C | |||||
| 2 | 80.2, CH | 4.36, dq (6, 12.6) | 162.9, C | |||
| 3 | 72.1, CH | 3.99, d (12.6) | 91.5, CH | 6.21, s | 70.1, CH2 | 5.17, s |
| 4 | 188.9, C | 166.2, C | 111.4, C | |||
| 4a | 97.6, C | 105.5, C | 143.8, C | |||
| 5 | 157.8, C | 104.1, C | 156.7, C | |||
| 6 | 124.3, CH | 7.09, d (13.2) | 149.2, C | |||
| 7 | 173.5, C | 119.8, CH | 7.15, d (13.2) | 136.6, C | ||
| 7a | 163.5, C | 103.9, C | ||||
| 8 | 99.1, CH | 5.90, s | 206, C | 10.7, CH3 | 2.06, s | |
| 8a | 176.5, C | |||||
| 9 | 36.5, CH2 | 2.48, t (7.2) | 46.7, CH2 | 2.98, t (7.2) | 61.2, OCH3 | 3.80, s |
| 10 | 19.9, CH2 | 1.71, qt (7.2, 7.8) | 18.8, CH2 | 1.67, qt (7.2, 7.8) | ||
| 11 | 13.5, CH3 | 0.98, t (7.8) | 14.2, CH3 | 0.96, t (7.8) | ||
| 12 | 18.2, CH3 | 1.64, d (6) | 56.2, OCH3 | 3.91, s | ||
| 4-OH | 15.11, s | |||||
a Measured in CDCl3. b Measured in acetone-d6. c Measured in Methanol-d4.
Figure 4X-ray structure of 4.
Antibacterial activities of Compounds 1–13.
| Strains | MIC (μg/mL) | |||||
|---|---|---|---|---|---|---|
| Compounds a | ||||||
| 6 | >100 | 50 | >100 | >100 | >100 | |
| 7 | >100 | 25 | 50 | >100 | >100 | |
| Ciprofloxacin b | 0.25 | 0.25 | 0.5 | 0.5 | 0.25 | |
a Compounds 1–5 and 8–13 showed no activity (MIC > 1 mg/mL). b Positive control. G+: Gram-positive bacteria. G−: Gram-negative bacteria.
DPPH free radical scavenging activities of Compounds 1–13.
| Compound | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | Vitamin C a |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IC50(μg/mL) | - | - | - | - | - | - | - | - | 62.9 | 13.6 | 12.1 | 18.1 | 11.7 | 18.2 |
-: no activity (IC50 > 100 μg/mL); a positive control.